Steve McClellan
Impact in
- Oncology top 10%
- Cancer Cells and Metastasis
- Cancer Research top 10%
- MicroRNA in disease regulation
- Cancer, Hypoxia, and Metabolism
Papers in
-
- RNA Interference and Gene Delivery 2
- Advanced biosensing and bioanalysis techniques 1
- Kruppel-like factors research 1
- Protein Degradation and Inhibitors 1
- Oncology 6
- Cancer Cells and Metastasis 4
- Co-authors
- Robert J. Cousins (1 shared paper)Juan P. Liuzzi (1 shared paper)Tolunay Beker Aydemir (1 shared paper)Michael A. Finan (2 shared papers)Rodney P. Rocconi (2 shared papers)Lalita A. Shevde (2 shared papers)Erhong Meng (2 shared papers)Eddie Reed (2 shared papers)
- Journals
- PLoS ONE (2 papers)British Journal of Cancer (1 paper)Journal of Clinical Oncology (1 paper)Journal of Leukocyte Biology (1 paper)The Journal of Urology (1 paper)
- Partner nations
- United StatesSwitzerlandItaly
In The Last Decade
Steve McClellan
10 papers receiving 762 citations
Peers
Comparison fields: 5 of 86
- Oncology 321
- Cancer Research 169
- Nutrition and Dietetics 148
- Reproductive Medicine 58
- Health, Toxicology and Mutagenesis 78
Countries citing papers authored by Steve McClellan
This map shows the geographic impact of Steve McClellan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Steve McClellan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Steve McClellan more than expected).
Fields of papers citing papers by Steve McClellan
This network shows the impact of papers produced by Steve McClellan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Steve McClellan. The network helps show where Steve McClellan may publish in the future.
Co-authors
The 25 scholars most cited alongside Steve McClellan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2009 | 180 | |
| 2 | 2012 | 148 | |
| 3 | 2014 | 127 | |
| 4 | 2010 | 101 | |
| 5 | 2010 | 69 | |
| 6 | 2015 | 56 | |
| 7 | 2012 | 44 | |
| 8 | 2021 | 27 | |
| 9 | 2021 | 18 | |
| 10 | 2019 | 1 | |
| 11 | 2021 | 0 |
About Steve McClellan
Steve McClellan is a scholar working on Molecular Biology, Oncology, Cancer Research, Pharmacology and Pathology and Forensic Medicine, having authored 11 papers that have together received 771 indexed citations. Recurring topics across this work include Cancer Cells and Metastasis (4 papers), RNA Interference and Gene Delivery (2 papers), Advanced biosensing and bioanalysis techniques (1 paper), Kruppel-like factors research (1 paper), Protein Degradation and Inhibitors (1 paper), MicroRNA in disease regulation (1 paper), Pharmacological Effects of Medicinal Plants (1 paper) and Cancer Research and Treatments (1 paper). The work is most often cited by research in Oncology (321 citations), Cancer Research (169 citations), Nutrition and Dietetics (148 citations), Reproductive Medicine (58 citations) and Health, Toxicology and Mutagenesis (78 citations). Steve McClellan has collaborated with scholars based in United States, Switzerland and Italy. Frequent co-authors include Robert J. Cousins, Juan P. Liuzzi, Tolunay Beker Aydemir, Michael A. Finan, Rodney P. Rocconi, Lalita A. Shevde, Erhong Meng, Eddie Reed, Lilian J. Oliveira and Peter J. Hansen. Their work appears in journals such as PLoS ONE, British Journal of Cancer, Journal of Clinical Oncology, Journal of Leukocyte Biology and The Journal of Urology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.